cdt-Articles_18- 16-Satya Lavanya - Copy.jpg


Lighting Times in Hospitals Affect Patients’ Health

Human beings are used to a cycle of light timings with light in the day and dark in the night. Accordingly, our mind and body feel active in daytime and laze afterwards. When we are exposed to light in inappropriate hours we tend to get irritated and find it hard to respond properly. Same phenomenon can get exacerbated if we are ill, as our body and mind is already fighting diseases and cannot bear extra agony. Yet this is a common sight in hospitals, medical centers and nursing homes that they are shining bright twenty-four hours – especially in the I.C.U. and other sensitive sections.


It has been ignored mostly but now researchers are paying attention to the potential ill-effects this untimely lighting has on our circadian rhythm, i.e. our biological clock. Scientists from University of Colorado suggest that if the hospitals, medical centers and the likes control their light intensity, duration and sunlight exposure than they may help patients recover quicker than otherwise. This subject is wide and welcoming for further research that can help improve the conditions.

Find out more on this topic from the research article, Entrainment of the Human Circadian Clock to the Light-Dark Cycle and its Impact on Patients in the ICU and Nursing Home Settings.

Highlighted Article Flyer for the journal “Current Neuropharmacology”



World Mental Health Day!


Today, on the 10th of October 2016, we raise awareness about the neurological, psychiatric and mental health disorders and their possible treatments with the rest of the world. Bentham Science Publishers has various research journals dedicated to the mental health research. The most significant ones are;

Current Neuropharmacology

Current Alzheimer Research

CNS & Neurological Disorders – Drug Targets

Highlighted Article Flyer for the journal “Current Neuropharmacology”

CN-Articles_14-4- A G Lewis


Bentham Science Press Release

Bentham Science Publishers is pleased to announce the launch of a number of  journals on the ScholarOne Manuscript site. Through this new electronic dashboard manuscripts  can be conveniently submitted, reviewed and their status checked.

Access the below mentioned links for submission:

Current Alzheimer Research         http://mc04.manuscriptcentral.com/cares
Current Medicinal Chemistry         http://mc04.manuscriptcentral.com/crmc
Current Drug Metabolism             http://mc04.manuscriptcentral.com/cdm
Current Pharmaceutical Biotechnology         http://mc04.manuscriptcentral.com/cpb
Current Molecular Medicine         http://mc04.manuscriptcentral.com/crmm
Current Neuropharmacology         http://mc04.manuscriptcentral.com/crn
Current Genomics                 http://mc04.manuscriptcentral.com/crg

Alzheimer’s Disease

Memories are noteworthy, Save them!9-22-2014 12-39-52 PM


Alzheimer’s disease, also common in medical literature, it is the most usual form of dementia. There is no such remedy for the illness, which intensifies as it progresses, and eventually causes death. It was firstly explained by a German psychiatrist and more over the neuropathologist. Alzheimer in 1906 and then it was coined after his name.

Most frequently, Alzheimer’s disease is diagnosed in individuals above 65 years of age, although the less-prevalent early-onset Alzheimer’s can occur much sooner. In 2006, there were 26.6 million people all over the globe suffering through this disease. Alzheimer’s is divined to affect 1 in 85 people by 2050. Although, Alzheimer’s disease evolves differently for every individual, there are many usual symptoms. Fresh symptoms are often mistakenly thought to be ‘age-related’ concerns, or manifestations of stress. In the initial stages, the most typical symptom is facing complexity in recalling current events, generally known as short term memory loss.

When Alzheimer Disease is suspected, the diagnosis is usually established with tests that assess behavior and philosophy abilities, often followed by a brain scan if accessible; however, examination of brain tissue is essential for a definitive diagnosis. As the disorder advances, symptoms can involve confusion, irritability, aggression, mood swings, trouble with language, and long-term memory loss. As the person’s condition declines they usually withdraw from family and society.

Gradually, bodily functions are lost, causing death. Since the disease is dissimilar for each individual, predicting how it will affect the person is strenuous. Alzheimer Disease expands for an unrevealed and variable amount of time before becoming fully apparent, and it can progress undiagnosed for years. On average, the life expectancy following diagnosis is approximately seven years. Fewer than 3% of individuals live more than 14 years after diagnosis. The first symptoms are often mistakenly attributed to ageing or stress.

Detailed neuropsychological testing can disclose mild cognitive difficulties up to eight years prior to a person fulfills the clinical criteria for diagnosis of Alzheimer Disease. These early symptoms can influence the most complex daily living activities. The most noticeable deficit is memory loss, which shows up as strain in remembering recently learned facts and inability to acquire fresh information.

%d bloggers like this: